AMDA’s Drive to Deprescribe (D2D) initiative put practitioners behind the wheel on medication optimization. During a recent AMDA On-The-Go podcast, guest host Jennifer Pruskowski, PharmD, MS, BCPS, BCGP, CPE, sat down with Michael Steinman, MD, co-director of the U.S. Deprescribing Research Network, to tal...
The aim of this study was to investigate the association between changes in depressive symptoms and sarcopenia by repeated measures of depressive symptoms at a follow-up visit every 2 years.
In response to the COVID-19 pandemic, Canadian governments and healthcare organizations implemented restrictions on continuing care residents. From an ethical lens, governments and healthcare organizations were focused on preventing harm through promoting beneficence and non-maleficence; however, this was ...
We investigate the changes in the sociodemographic characteristics, clinical comorbidities, and transitions between care settings among residents of assisted living facilities.
The purpose of this study was to test a model of the resident and community factors that are associated with quality of care interactions among nursing home (NH) residents living with dementia and test for invariance between model fit when tested with the Black versus White residents and female versus male...
Last week, the Moving Forward Nursing Home Quality Coalition released its nine action plans for nursing homes. Each action plan describes a particular challenge facing nursing homes today, explains why it is important to residents’ quality of life, defines focused goals to address those challenges, and pro...
Tools, knowledge, and recognition to improve vaccination rates and protect residents and staff.